Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
about
Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@en
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@nl
type
label
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@en
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@nl
prefLabel
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@en
Targeting Pioglitazone Hydroch ...... roke or Myocardial Infarction.
@nl
P2093
P2860
P1433
P1476
Targeting Pioglitazone Hydroch ...... troke or Myocardial Infarction
@en
P2093
Amber Stuart
Catherine M Viscoli
David M Kent
Insulin Resistance Intervention After Stroke (IRIS) Trial Investigators
Karen L Furie
Lawrence H Young
Mark Gorman
Peter D Guarino
Pierre Fayad
Robin Conwit
P2860
P304
P356
10.1001/JAMANEUROL.2017.2136
P407
P577
2017-11-01T00:00:00Z